Health Cost Control

Health Cost Control was a U.S. healthcare cost-containment company focused on claim and cost review services for self-insured employers, health plans, third-party administrators, and insurance companies. The company specialized in identifying billing inaccuracies and documentation issues in high-dollar claims, including dialysis, air ambulance, and behavioral health billing. Its services included medical bill review, repricing to usual, customary and reasonable levels, and related cost-savings programs designed to reduce employer healthcare spend. In September 2022, Health Cost Control was acquired by Valenz and its capabilities were integrated into Valenz's broader healthcare ecosystem and claims management offering. It was not a drug-development biotech or pharma company, but rather a healthcare services business operating in payment integrity and medical cost management.